tiprankstipranks

Michael Severino Insider Profile

4 Followers
Michael Severino, Chief Executive Officer, Director at Sarepta Therapeutics, holds 756.10K shares in Sarepta Therapeutics (Ticker: SRPT), holds 85.82K shares in Avantor (Ticker: AVTR), holds 26.03K shares in Viatris (Ticker: VTRS).
tipranks
Michael Severino

Michael Severino
Sarepta Therapeutics (SRPT)
Chief Executive Officer, Director

Ranked #49,413 out of 108,921 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+2.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$58M
67.55%
29.46%
2.22%
0.76%
A breakdown of Michael Severino's holdings

Insider Roles

AbbVie
(ABBV)
Vice Chairman
Sarepta Therapeutics
(SRPT)
Chief Executive Officer, Director
Avantor
(AVTR)
Director
Viatris
(VTRS)
Director
Roles that Michael Severino holds in companies

Most Profitable Insider Trade

Stock:
AbbVie
(ABBV)
Rating:Informative Sell
Date:May 25, 2022 - May 25, 2023
Return:+5.20%
The most profitable trade made by Michael Severino

Michael Severino's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sarepta Therapeutics
Jul 29, 2026
Chief Executive Officer, Director
Uninformative Buy
$17.01M
AbbVie
May 25, 2022
Vice Chairman
Uninformative Buy
8.70M
$39.01M
Avantor
May 11, 2026
Director
Uninformative Buy
$1.28M
Viatris
Mar 10, 2026
Director
Uninformative Buy
368.60K
$439.40K
List of latest transactions for each holding click on a transaction to see Michael Severino's performance on stock

Michael Severino insider profile FAQ

What is the percentage of profitable transactions made by Michael Severino?
The percentage of profitable transactions made by Michael Severino is 67%.
    What is the average return per transaction made by Michael Severino?
    The average return per transaction made by Michael Severino is 2.40%.
      What stocks does Michael Severino hold?
      Michael Severino holds: SRPT, ABBV, AVTR, VTRS stocks.
        What was Michael Severino’s latest transaction?
        Michael Severino latest transaction was an Uninformative Buy of ―.
          What was Michael Severino's most profitable transaction?
          Michael Severino’s most profitable transaction was an Informative Sell of ABBV stock on May 25, 2022. The return on the trade was 5.20%.
            What is Michael Severino's role in Sarepta Therapeutics?
            Michael Severino's role in Sarepta Therapeutics is Chief Executive Officer, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.